Medical Advertising Hall of Fame selects its ’06 honorees

Share this article:
The Medical Advertising Hall of Fame has selected four industry leaders to be honored with induction during its awards dinner on Feb. 8, 2006, at the Pierre Hotel in New York City.
The honorees are:
• Philip Brady, a former president
of R.W. Rosenthal and Thomas G.
• Fred Mann, a founder of Cline
Davis & Mann,
• Lou Carrafiello, a founder of
Carrafiello Diehl, and
• August "Gus" Fink, a founder of the publication Patient Care.
Additionally, the late Adam Piret, a moving force in establishing the Pharmaceutical Advertising Club (PAC, now HMCC) in 1937, has been selected to receive MAHF's coveted service to industry award.
Brady and Mann are expected to accept their awards personally at the awards dinner. Family or friends will accept for Carrafiello and Fink, who are deceased.
The four inductees finished at the top of a list of 20 nominees voted upon by the MAHF's Council of Judges, which is made up of leaders of the 50 leading medical advertising
The MAHF's Executive Committee certified the election of new members at its Nov. 9, 2005, meeting.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...